| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/11/2011 | CN101428143B Attenuated bacteria vector tuberculosis vaccine carrying tuberculosis gene, preparation method and application thereof |
| 05/11/2011 | CN101314616B Hemorrhagic bacillus coli of intestine 0157:H7 shiga toxin IIB epitope peptide and uses thereof |
| 05/11/2011 | CN101254302B Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 05/11/2011 | CN101212983B A vaccine composition comprising alpha-galactosylceramide as an adjuvant for intranasal administration |
| 05/11/2011 | CN101116745B Human papilloma virus sample particle vaccines |
| 05/11/2011 | CN101090974B Multivalent vaccines comprising recombinant viral vectors |
| 05/11/2011 | CN101062414B Application of anti-intercellular adhesion molecule-1 monoclonal antibody for preparing medicine for treating avian influenza |
| 05/10/2011 | US7939650 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer |
| 05/10/2011 | US7939646 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/10/2011 | US7939641 Comprises fusion proteins for diagnosis and treatment of creutzfeldt- jakob, nervous system, atherosclerosis, diabetes, amyloidosis and viral infections |
| 05/10/2011 | US7939639 Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology |
| 05/10/2011 | US7939637 Insulin-like growth factor antibodies and uses thereof |
| 05/10/2011 | US7939503 Nucleotide sequences coding six transmembrane epithelial antigen of the prostate (STEAP)-1) for use as tool in diagnosis, prevention and treatment of cell proliferative disorders; RNA intereference |
| 05/10/2011 | US7939497 Preventing or treating a disease or disorder associated with Slit2 mediated angiogenesis in a subject by use of pharmaceutical composition comprising a substance that reduces or enhances Slit2-Slit2 receptor interaction |
| 05/10/2011 | US7939492 Factor C for treating gram-negative bacterial infection |
| 05/10/2011 | US7939490 TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death |
| 05/10/2011 | US7939321 TADG-15: an extracellular serine protease overexpressed in carcinomas |
| 05/10/2011 | US7939318 Flexible vaccine assembly and vaccine delivery platform |
| 05/10/2011 | US7939281 Method to identify patients at risk for lung transplant rejection |
| 05/10/2011 | US7939268 Compositions and methods for the diagnosis and treatment of tumor |
| 05/10/2011 | US7939112 Pharmaceutical compositions containing bulbophyllum and their use for treating illnesses |
| 05/10/2011 | US7939090 System and method for the treatment of cancer, including cancers of the central nervous system |
| 05/10/2011 | US7939089 Transgenic mycobacterium for use as bioreactor in production of neoplastic proteins |
| 05/10/2011 | US7939088 Streptococcus phocae vaccine |
| 05/10/2011 | US7939087 Nucleic acids and proteins from Streptococcus groups A & B |
| 05/10/2011 | US7939086 Modified Vaccinia Ankara virus variant |
| 05/10/2011 | US7939085 Attenuated myxomavirus that has lost receptor properties of myxomavirus interferon receptor or myxomavirus tumor necrosis factor receptor or myxomavirus interleukin receptor; causes an increase in number of leukocytes in human patient 7 days after administration |
| 05/10/2011 | US7939084 Vaccine against varicella zoster virus |
| 05/10/2011 | US7939083 Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomain |
| 05/10/2011 | US7939082 Papilloma virus vaccine |
| 05/10/2011 | US7939080 HER-2 binding antagonists |
| 05/10/2011 | US7939079 Helicobacter species and cultivation thereof |
| 05/10/2011 | US7939077 DNA sequences that code antibodies or fragments; genetic vectors and host cells transformed by the vector, used for diagnosis and prophylaxis of cancer |
| 05/10/2011 | US7939076 interferon antagonists, such as anti-type 1 interferon receptor antibody antagonists and fragments, as well as polypeptides and small molecules that inhibit the interaction of type 1 interferon with its cell-surface receptors; treatment of gastrointerstinal disorders and autoimmune diseases |
| 05/10/2011 | US7939075 Human monoclonal anti-amyloid-beta antibodies |
| 05/10/2011 | US7939074 Combination of an anti-EP-CAM antibody with a chemotherapeutic agent |
| 05/10/2011 | US7939073 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 05/10/2011 | US7939072 Anti-EGFR antibodies with an improved anti-tumor activity and compositions and articles of manufacture comprising same |
| 05/10/2011 | US7939071 Artery- and vein-specific proteins and uses therefor |
| 05/10/2011 | US7939070 IL-17 receptor A antigen binding proteins |
| 05/10/2011 | US7939069 Monoclonal antibody specific for brain natriuretic peptide for use in diagnosis, prevention and treatment of cardiovascular disorders |
| 05/10/2011 | US7939068 Antagonizing signal transduction in dorsal root ganglion cells in a subject with IL-31 antagonists |
| 05/10/2011 | US7939062 Methods for human allografting |
| 05/10/2011 | CA2459754C Vaccinia virus mva-e3l-knock-out-mutants and use thereof |
| 05/10/2011 | CA2439170C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 05/10/2011 | CA2417806C New immunoeffector compounds |
| 05/10/2011 | CA2399866C Compositions and methods for treatment of angiogenesis in pathological lesions |
| 05/10/2011 | CA2387576C Immuno-interactive fragments of the .alpha.c subunit of inhibin |
| 05/10/2011 | CA2306441C Peptides derived from the env gene of the feline immunodeficiency virus and their applications |
| 05/10/2011 | CA2304810C Tie receptor tyrosine kinase ligand homologues |
| 05/10/2011 | CA2295858C Rhabdoviruses with reengineered coats |
| 05/10/2011 | CA2292898C Bacterial pheromones and uses therefor |
| 05/10/2011 | CA2236538C Influenza vaccine compositions |
| 05/10/2011 | CA2165458C Intracellular binding proteins and use thereof |
| 05/06/2011 | CA2699024A1 Methods of immunizing pregnant heifers at three months of gestation |
| 05/05/2011 | WO2011054007A1 Ror1 as therapeutic and diagnostic target |
| 05/05/2011 | WO2011053959A1 Apparatus and method for cryogranulating a pharmaceutical composition |
| 05/05/2011 | WO2011053848A1 Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms |
| 05/05/2011 | WO2011053798A2 Peptide compositions and methods for inhibiting herpesvirus infection |
| 05/05/2011 | WO2011053783A2 Ax213 and ax132 pcsk9 antagonists and variants |
| 05/05/2011 | WO2011053763A2 Il-17a antagonists |
| 05/05/2011 | WO2011053759A1 Ax1 and ax189 pcsk9 antagonists and variants |
| 05/05/2011 | WO2011053730A1 Method for making targeted therapeutic agents directed to soluble targets |
| 05/05/2011 | WO2011053707A1 Antibodies to receptor for advanced glycation end products (rage) and uses thereof |
| 05/05/2011 | WO2011053630A1 Uses of a mammalian cytokine |
| 05/05/2011 | WO2011053565A2 Compositions and methods for detecting a tauopathy |
| 05/05/2011 | WO2011053331A1 Vaccine compositions and methods of use |
| 05/05/2011 | WO2011053322A1 Use of autologous effector cells and antibodies for treatment of multiple myeloma |
| 05/05/2011 | WO2011052906A2 Use of eif3m for the diagnosis and treatment of cancer |
| 05/05/2011 | WO2011052799A1 Compositions and methods for treating inflammatory disorders |
| 05/05/2011 | WO2011052771A1 Nebulizable tuberculosis vaccine for transnasal administration comprising paramyxovirus vector |
| 05/05/2011 | WO2011052753A1 Antibody binding to mansc1 protein and having anticancer activity |
| 05/05/2011 | WO2011052735A1 Antibody having activity of inhibiting infection with hepatitis c virus (hcv) and use of same |
| 05/05/2011 | WO2011052697A1 Protein having cedar pollen immunogenicity, polynucleotide for coding for said protein, and uses of said protein and polynucleotide |
| 05/05/2011 | WO2011051917A1 Purification of staphylococcus aureus type 5 and type 8 capsular saccharides |
| 05/05/2011 | WO2011051893A1 Modified meningococcal fhbp polypeptides |
| 05/05/2011 | WO2011051657A1 Thymic stromal lymphopoietin as an adjuvant for a vaccine |
| 05/05/2011 | WO2011051445A1 Process for preparing an influenza seed virus for vaccine manufacture |
| 05/05/2011 | WO2011051307A1 Dosage regimen for administering a cd19xcd3 bispecific antibody |
| 05/05/2011 | WO2011051288A1 Podxl protein in colorectal cancer |
| 05/05/2011 | WO2011051235A1 Process for producing influenza vaccine |
| 05/05/2011 | WO2011051217A1 Stable anti-tnfr1 polypeptides, antibody variable domains & antagonists |
| 05/05/2011 | WO2011050459A1 Methods and uses for treating hepatic ischemia and reperfusion injury |
| 05/05/2011 | WO2011050431A2 Dna vaccine against virus of yellow fever |
| 05/05/2011 | WO2011050384A2 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection |
| 05/05/2011 | WO2011028883A3 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 05/05/2011 | WO2011027222A3 Immunogenic compositions including tlr activity modulators |
| 05/05/2011 | WO2011024071A9 Adjuvant comprising aluminium, oligonucleotide and polycation |
| 05/05/2011 | WO2011022656A3 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 05/05/2011 | WO2011019423A3 Modulation of pilr receptors to treat microbial infections |
| 05/05/2011 | WO2011009771A3 Immunogenic and therapeutic compositions for streptococcus suis |
| 05/05/2011 | WO2011007339A3 Chimeric foot and mouth disease viruses |
| 05/05/2011 | WO2010151076A3 Adjuvant composition comprising (poly-gamma-glutamate)-chitosan nanoparticles |
| 05/05/2011 | WO2010135521A3 Compositions and methods for the therapy and diagnosis of influenza |
| 05/05/2011 | WO2010099472A8 Spanx-b polypeptides and their use |
| 05/05/2011 | WO2010040000A8 A multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia |
| 05/05/2011 | WO2010012069A8 Multivalent vaccines based on papaya mosaic virus and uses thereof |
| 05/05/2011 | US20110105996 Methods for scar prevention |
| 05/05/2011 | US20110105731 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 05/05/2011 | US20110105721 Peptides |